Financials Alkim Alkali Kimya

Equities

ALKIM

TRAALKIM91E0

Paper Products

Market Closed - Borsa Istanbul 11:09:29 2024-05-06 am EDT 5-day change 1st Jan Change
38.5 TRY +0.05% Intraday chart for Alkim Alkali Kimya -2.53% +12.97%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 586 947.5 2,235 2,530 5,877 5,112
Enterprise Value (EV) 1 546.1 849.6 2,089 2,271 5,707 4,491
P/E ratio 6.73 x 7.2 x 11.2 x 10.2 x 10.3 x 18.9 x
Yield 8.23% - - - 2.36% -
Capitalization / Revenue 0.99 x 1.37 x 2.96 x 2.31 x 2.1 x 1.27 x
EV / Revenue 0.93 x 1.23 x 2.77 x 2.07 x 2.04 x 1.12 x
EV / EBITDA 3.97 x 4.87 x 9.12 x 8.55 x 7.38 x 6.84 x
EV / FCF 17.5 x 10.9 x 16.7 x 6,822 x -44.3 x 4.36 x
FCF Yield 5.7% 9.19% 6% 0.01% -2.26% 22.9%
Price to Book 1.84 x 2.43 x 4.48 x 3.79 x 5.34 x 1.99 x
Nbr of stocks (in thousands) 150,000 150,000 150,000 150,000 150,000 150,000
Reference price 2 3.907 6.316 14.90 16.87 39.18 34.08
Announcement Date 2/27/19 2/27/20 2/25/21 2/24/22 2/28/23 3/27/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 589.2 691.4 754.1 1,096 2,797 4,026
EBITDA 1 137.5 174.6 229.1 265.5 773.7 656.6
EBIT 1 116.7 152.2 207.8 242.4 741.6 521.9
Operating Margin 19.81% 22.01% 27.56% 22.11% 26.51% 12.96%
Earnings before Tax (EBT) 1 118.3 162.6 234.9 354.2 840.8 221.1
Net income 1 87.1 131.5 199.2 248.1 572.3 271.1
Net margin 14.78% 19.02% 26.41% 22.63% 20.46% 6.73%
EPS 2 0.5807 0.8768 1.328 1.654 3.815 1.807
Free Cash Flow 1 31.15 78.12 125.4 0.3329 -128.7 1,029
FCF margin 5.29% 11.3% 16.63% 0.03% -4.6% 25.55%
FCF Conversion (EBITDA) 22.66% 44.75% 54.73% 0.13% - 156.69%
FCF Conversion (Net income) 35.76% 59.4% 62.96% 0.13% - 379.56%
Dividend per Share 2 0.3214 - - - 0.9259 -
Announcement Date 2/27/19 2/27/20 2/25/21 2/24/22 2/28/23 3/27/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q3 2022 Q4
Net sales 1 275.4 390.9 - 749.6
EBITDA 1 41.39 114.7 - 170
EBIT - - - -
Operating Margin - - - -
Earnings before Tax (EBT) - - - -
Net income 1 27.14 141.6 161 129.7
Net margin 9.85% 36.22% - 17.3%
EPS - - 0.0107 -
Dividend per Share - - - -
Announcement Date 11/8/21 2/24/22 11/8/22 2/28/23
1TRY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 39.9 97.8 146 260 170 621
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 31.2 78.1 125 0.33 -129 1,029
ROE (net income / shareholders' equity) 30.3% 36.4% 44.8% 44.6% 67.3% 10.6%
ROA (Net income/ Total Assets) 16.8% 18.5% 19.9% 15.9% 32% 9.04%
Assets 1 518.2 712.8 1,002 1,560 1,787 3,000
Book Value Per Share 2 2.120 2.600 3.330 4.450 7.340 17.10
Cash Flow per Share 2 0.6000 1.000 1.290 2.240 1.580 3.570
Capex 1 16.7 21.1 18.8 146 114 124
Capex / Sales 2.83% 3.06% 2.5% 13.29% 4.08% 3.09%
Announcement Date 2/27/19 2/27/20 2/25/21 2/24/22 2/28/23 3/27/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
38.5 TRY
Average target price
56 TRY
Spread / Average Target
+45.45%
Consensus

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALKIM Stock
  4. Financials Alkim Alkali Kimya
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW